Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-Interleukin Receptor-AIK3a305
AIK3a305

Chemical Structure : AIK3a305

CAS No.: 2419902-92-2

AIK3a305 (AIK3-305)

Catalog No.: PC-26254Not For Human Use, Lab Use Only.

AIK3a305 (AIK3-305) is an allosteric inhibitor of Jmitogen-activated protein kinases (MAPK), particularly JNK, and a potent and selective, orally available inhibitor IL-1β release in human monocyte-derived macrophages with IC50 of 28 nM.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

AIK3a305 (AIK3-305) is an allosteric inhibitor of Jmitogen-activated protein kinases (MAPK), particularly JNK, and a potent and selective, orally available inhibitor IL-1β release in human monocyte-derived macrophages with IC50 of 28 nM.
AIK3a305 does not interfere expression levels of IL-1α, IL-2, IL-6, IL-8 or GM-CSF.
AIK3a305 shows direct biophysical interactions to p38α MAPK with SPR KD of 12 nM.
AIK3a305 (10-20 mg/kg) inhibits IL-1β secretion in LPS endotoxic shock model in male BALB/c mice.
AIK3a305 selectively inhibited LPS- and palmitate-induced IL1β expression in macrophages, while protecting hepatocytes from intracellular lipid accumulation and lipoapoptosis.
AIK3a305 attenuated disease progression in animals fed either a HFD or a CDAA diet, as evidenced by improved liver histopathology, including reduced steatosis and inflammation, in preclinical models of MASLD.

Physicochemical Properties

M.Wt 532.05
Formula C26H30ClN3O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

6-(4-(4-chlorophenoxy)piperidin-1-yl)-5-(4-ethoxyphenoxy)-N,N-dimethylpyridine-3-sulfonamide

References

1. Berlana Á, et al. Biomed Pharmacother. 2026 Feb;195:119052.

2. Zegarra-Valdivia JA, et al. Geroscience. 2022 Aug;44(4):2243-2257.

3. Carrasco E, et al. Eur J Med Chem. 2021 Nov 5;223:113620.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: